Human Immunodeficiency Virus Type 1 Genotypic and Pharmacokinetic Determinants of the Virological Response to Lopinavir-Ritonavir-Containing Therapy in Protease Inhibitor-Experienced Patients

The response to regimens including lopinavir-ritonavir (LPV/r) in patients who have received multiple protease (PR) inhibitors (PI) can be analyzed in terms of human immunodeficiency virus type 1 (HIV-1) genotypic and pharmacokinetic (pK) determinants. We studied these factors and the evolution of H...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Masquelier, Bernard, Breilh, Dominique, Neau, Didier, Lawson-Ayayi, Sylvie, Lavignolle, Valérie, Ragnaud, Jean-Marie, Dupon, Michel, Morlat, Philippe, Dabis, F., Fleury, H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2002
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC127404/
https://ncbi.nlm.nih.gov/pubmed/12183249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.9.2926-2932.2002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados